Details of Protein
General Information of Protein (ID: PRT00979) | |||||
---|---|---|---|---|---|
Name | Neuropeptide Y (NPY) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Npy
|
||||
Gene Name | Npy | Gene ID | |||
UniProt ID | |||||
Family | Neuropeptide Y (NPY) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MMLGNKRMGLCGLTLALSLLVCLGILAEGYPSKPDNPGEDAPAEDMARYYSALRHYINLI
TRQRYGKRSSPETLISDLLMRESTENAPRTRLEDPSMW |
||||
Function | NPY is implicated in the control of feeding and in secretion of gonadotrophin-release hormone. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Benzenoids | ||||||
3,4-Dihydroxybenzeneacetic acid | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Antagonist ([D-Trp32]NPY) of Npy | |||||
Induced Change | 3,4-Dihydroxybenzeneacetic acid concentration: increase (FC = 1.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that Antagonist ([D-Trp32]NPY) of Npy leads to the increase of 3,4-dihydroxybenzeneacetic acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Npy | |||||
Induced Change | 3,4-Dihydroxybenzeneacetic acid concentration: increase (FC = 2.00) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Npy leads to the increase of 3,4-dihydroxybenzeneacetic acid levels compared with control group. | |||||
Homovanillic acid | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Antagonist ([D-Trp32]NPY) of Npy | |||||
Induced Change | Homovanillic acid concentration: increase (FC = 2.20) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that antagonist [D-Trp32]NPY of Npy leads to the increase of homovanillic acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Npy | |||||
Induced Change | Homovanillic acid concentration: increase (FC = 3.00) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Npy leads to the increase of homovanillic acid levels compared with control group. | |||||
Norepinephrine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Antagonist ([D-Trp32]NPY) of Npy | |||||
Induced Change | Norepinephrine concentration: increase (FC = 1.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that antagonist [D-Trp32]NPY of Npy leads to the increase of norepinephrine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Npy | |||||
Induced Change | Norepinephrine concentration: increase (FC = 1.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Npy leads to the increase of norepinephrine levels compared with control group. | |||||
Organoheterocyclic compounds | ||||||
Thiamine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Antagonist ([D-Trp32]NPY) of Npy | |||||
Induced Change | Thiamine concentration: increase (FC = 2.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that antagonist [D-Trp32]NPY of Npy leads to the increase of thiamine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Npy | |||||
Induced Change | Thiamine concentration: increase (FC = 2.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Npy leads to the increase of thiamine levels compared with control group. | |||||
Full List of Metabolite(s) Regulating This Protein | ||||||
---|---|---|---|---|---|---|
Organic acids and derivatives | ||||||
Leucine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Leucine addition (504 hours) | |||||
Induced Change | NPY mRNA levels: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Stomach cancer [ICD-11: 2B72] | |||||
Details | It is reported that leucine addition causes the decrease of NPY mRNA levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.